Decreased expression of γ-carboxylase in diabetes-associated arterial stiffness: Impact on matrix Gla protein

Cardiovascular Research

Volumn 97, Issue 2, 2013, Pages 331-338

  Doyon, Marielle ^a   Mathieu, Patrick ^b   Moreau, Pierre ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Carboxylase; Arterial stiffness; Diabetes; Matrix Gla protein; VKOR

Indexed keywords

4 CARBOXYGLUTAMIC ACID; CARBOXYLASE; GAMMA CARBOXYLASE; UNCLASSIFIED DRUG; VITAMIN K GROUP;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL STIFFNESS; ARTERY CALCIFICATION; ARTICLE; BLOOD VESSEL CALCIFICATION; CONTROLLED STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR RING;

ANIMALS; AORTA; CALCIUM-BINDING PROTEINS; CARBON-CARBON LIGASES; CHYLOMICRON REMNANTS; DIABETES MELLITUS, EXPERIMENTAL; EXTRACELLULAR MATRIX PROTEINS; MALE; NAD(P)H DEHYDROGENASE (QUINONE); OSTEOCALCIN; RATS; RATS, WISTAR; STREPTOZOCIN; VASCULAR CALCIFICATION; VASCULAR STIFFNESS; VITAMIN K;

EID: 84872570664     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs325     Document Type: Article

References (47)

1. Safar ME, Jankowski P. Central blood pressure and hypertension: role in cardiovascular risk assessment. Clin Sci (Lond) 2009;116:273-282.
2. Greenwald SE. Ageing of the conduit arteries. J Pathol 2007;211:157-172.
3. O'Rourke MF. Isolated systolic hypertension, pulse pressure, and arterial stiffness as risk factors for cardiovascular disease. Curr Hypertens Rep 1999;1:204-211.
4. Watabe D, Hashimoto J, Hatanaka R, Hanazawa T, Ohba H, Ohkubo T et al. Electrocardiographic left ventricular hypertrophy and arterial stiffness: the Ohasama study. Am J Hypertens 2006;19:1199-1205.
5. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002;39:10-15.
6. O'Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005;46: 200-204.
7. Benetos A, Safar M, Rudnichi A, Smulyan H, Richard JL, Ducimetieere P et al. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 1997;30:1410-1415.
8. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001;37:1236-1241.
9. Cockcroft JR, Wilkinson IB. Large arterial stiffness: an important therapeutic target. J Hum Hypertens 2000;14:533-535.
10. Urbina EM,Wadwa RP, Davis C, Snively BM, Dolan LM, Daniels SR et al. Prevalence of increased arterial stiffness in children with type 1 diabetes mellitus differs by measurement site and sex: the SEARCH for Diabetes in Youth Study. J Pediatr 2010;156: 731-737, 737 e731.
11. Berry KL, Skyrme-Jones RA, Cameron JD, O'Brien RC, Meredith IT. Systemic arterial compliance is reduced in young patients with IDDM. Am J Physiol 1999;276: H1839-1845.
12. Brooks B, Molyneaux L, Yue DK. Augmentation of central arterial pressure in type 1 diabetes. Diabetes care 1999;22:1722-1727.
13. Giannattasio C, Failla M, Grappiolo A, Gamba PL, Paleari F, Mancia G. Progression of large artery structural and functional alterations in Type I diabetes. Diabetologia 2001; 44:203-208.
14. Ronnback M, Fagerudd J, Forsblom C, Pettersson-Fernholm K, Reunanen A, Groop PH. Altered age-related blood pressure pattern in type 1 diabetes. Circulation 2004;110:1076-1082.
15. Cameron JD, Cruickshank JK. Glucose, insulin, diabetes and mechanisms of arterial dysfunction. Clin Exp Pharmacol Physiol 2007;34:677-682.
16. Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia 2008;51:527-539.
17. Mackey RH, Venkitachalam L, Sutton-Tyrrell K. Calcifications, arterial stiffness and atherosclerosis. Adv Cardiol 2007;44:234-244.
18. Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996;16:978-983.
19. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386:78-81.
20. Price PA, Faus SA, Williamson MK. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998;18: 1400-1407.
21. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME. Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 1999;100:2168-2176.
22. Berkner KL. The vitamin K-dependent carboxylase. J Nutr 2000;130:1877-1880.
23. Rishavy MA, Usubalieva A, Hallgren KW, Berkner KL. Novel insight into the mechanism of the vitamin K oxidoreductase (VKOR): electron relay through Cys43 and Cys51 reduces VKOR to allow vitamin K reduction and facilitation of vitamin Kdependent protein carboxylation. J Biol Chem 2011;286:7267-7278.
24. Schurgers LJ, Teunissen KJ, Knapen MH, Kwaijtaal M, van Diest R, Appels A et al. Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol 2005;25:1629-1633.
25. Essalihi R, Dao HH, Yamaguchi N, Moreau P. A new model of isolated systolic hypertension induced by chronic warfarin and vitamin K1 treatment. Am J Hypertens 2003; 16:103-110.
26. Schagger H, von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987;166:368-379.
27. Chu PH, Huang TY, Williams J, Stafford DW. Purified vitamin K epoxide reductase alone is sufficient for conversion of vitamin K epoxide to vitamin K and vitamin K to vitamin KH2. Proc Natl Acad Sci USA 2006;103:19308-19313.
28. Fu X, Peterson JW, Hdeib M, Booth SL, Grusak MA, Lichtenstein AH et al. Measurement of deuterium-labeled phylloquinone in plasma by high-performance liquid chromatography/mass spectrometry. Anal Chem 2009;81:5421-5425.
29. Bouvet C, Peeters W, Moreau S, DeBlois D, Moreau P. A new rat model of diabetic macrovascular complication. Cardiovasc Res 2007;73:504-511.
30. Dao HH, Essalihi R, Bouvet C, Moreau P. Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension. Cardiovasc Res 2005;66:307-317.
31. Young MJ, Adams JE, Anderson GF, Boulton AJ, Cavanagh PR. Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia 1993;36:615-621.
32. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006;27:2588-2605.
33. Canfield AE, Farrington C, Dziobon MD, Boot-Handford RP, Heagerty AM, Kumar SN et al. The involvement of matrix glycoproteins in vascular calcification and fibrosis: an immunohistochemical study. J Pathol 2002;196:228-234.
34. Laurent S. Surrogate measures of arterial stiffness: do they have additive predictive value or are they only surrogates of a surrogate? Hypertension 2006;47:325-326.
35. Safar M. Arteries in Clinical Hypertension. Philadelphia: Lippincott-Raven, 1994.
36. Gao X, Xu Y, Xu B, Liu Y, Cai J, Liu HM et al. Allopurinol attenuates left ventricular dysfunction in rats with early stage of streptozotocin-induced diabetes. Diabetes Metab Res Rev 2012;28:409-417.
37. Zhou YB, Zhang J, Cai Y, Teng X, Duan XH, Song JQ et al. Insulin resistance induces medial artery calcification in fructose-fed rats. Exp Biol Med 2012;237:50-57.
38. Bostrom KI, Jumabay M, Matveyenko A, Nicholas SB, Yao Y. Activation of vascular bone morphogenetic protein signaling in diabetes mellitus. Circ Res 2011;108:446-457.
39. Wang Y, Zhang B, Bai Y, Zeng C, Wang X. Changes in proteomic features induced by insulin on vascular smooth muscle cells from spontaneous hypertensive rats in vitro. Cell Biochem Biophys 2010;58:97-106.
40. Wang T, Yang J, Qiao J, Liu J, Guo X, Ye Z. Activity and expression of vitamin Kdependent gamma-glutamyl carboxylase in patients with calcium oxalate urolithiasis. Urol Int 2010;85:94-99.
41. Vanakker OM, Martin L, Schurgers LJ, Quaglino D, Costrop L, Vermeer C et al. Low serum vitamin K in PXE results in defective carboxylation of mineralization inhibitors similar to the GGCX mutations in the PXE-like syndrome. Lab Invest 2010;90: 895-905.
42. Rennenberg RJ, de Leeuw PW, Kessels AG, Schurgers LJ, Vermeer C, van Engelshoven JM et al. Calcium scores and matrix Gla protein levels: association with vitamin K status. Eur J Clin Invest 2010;40:344-349.
43. Williams KJ, Chen K. Recent insights into factors affecting remnant lipoprotein uptake. Curr Opin Lipidol 2010;21:218-228.
44. Kohlmeier M, Salomon A, Saupe J, Shearer MJ. Transport of vitamin K to bone in humans. J Nutr 1996;126:1192S-1196S.
45. Saupe J, Shearer MJ, Kohlmeier M. Phylloquinone transport and its influence on gamma-carboxyglutamate residues of osteocalcin in patients on maintenance hemodialysis. Am J Clin Nutr 1993;58:204-208.
46. Sadowski JA, Hood SJ, Dallal GE, Garry PJ. Phylloquinone in plasma from elderly and young adults: factors influencing its concentration. Am J Clin Nutr 1989;50:100-108.
47. Reaven EP, Reaven GM. Mechanisms for development of diabetic hypertriglyceridemia in streptozotocin-treated rats. Effect of diet and duration of insulin deficiency. J Clin Invest 1974;54:1167-1178.